| Alligator Bioscience AB. (4/15/21). "Press Release: Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy". Lund. |
2021-04-15 |
| Ori Biotech Ltd.. (4/14/21). "Press Release: ATMPS and Ori Biotech Collaborate on an Integrated Digital Platform for Cell and Gene Therapy Developers". London & Woodcliff Lake, NJ. |
2021-04-14 |
| Biognosys AG. (4/13/21). "Press Release: Biognosys Announces Strategic Agreement with Siemens Healthineers". |
2021-04-13 |
| Genovis AB. (4/13/21). "Press Release: Genovis and Waters Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization". |
2021-04-13 |
| Repertoire Immune Medicines. (4/13/21). "Press Release: Repertoire Immune Medicines Secures $189M Financing to Advance Pipeline Programs and Discovery Platform Directed at Cellular Immune Targets". Cambridge, MA. |
2021-04-13 |
| Evotec SE. (4/13/21). "Press Release: Evotec Launches »beLAB2122«, Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb". Hamburg. |
2021-04-13 |
| Jaguar Gene Therapy, LLC. (4/13/21). "Press Release: Jaguar Gene Therapy Closes $139 Million Series B Funding Co-led by Eli Lilly and Company and Deerfield Management". Lake Forest, IL. |
2021-04-13 |
| F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna. |
2021-04-12 |
| CellGenix GmbH. (4/12/21). "Press Release: CellGenix Appoints Daniel Spatz as Vice President Sales, Marketing & Logistics and Member of the Management Team". Freiburg. |
2021-04-12 |
| DiaSorin S.p.A.. (4/11/21). "Press Release: DiaSorin to Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion". Saluggia. |
2021-04-11 |
| Sanofi S.A.. (4/9/21). "Press Release: Sanofi Acquires Tidal Therapeutics, Adding Innovative mRNA-based Research Platform with Applications in Oncology, Immunology, and other Disease Areas". Paris & Cambridge, MA. |
2021-04-09 |
| Future Planet Capital Ltd.. (4/8/21). "Press Release: Future Planet Acquires One of the UK’s Oldest VC Firms". |
2021-04-08 |
| Hologic, Inc.. (4/8/21). "Press Release: Hologic to Acquire Mobidiag, Innovator in Near-Patient, Acute Care Diagnostic Testing, for Approximately $795 Million". Marlborough, MA. |
2021-04-08 |
| Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Extends Series A Financing from RA Capital and Welcomes Andrew Levin to Its Board of Directors". Emeryville, CA. |
2021-04-07 |
| Artios Pharma Ltd.. (4/7/21). "Press Release: Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies". Cambridge & New York, NY. |
2021-04-07 |
| Metagenomi Inc.. (4/7/21). "Press Release: Metagenomi Announces the Addition of Leading Immuno-oncology Clinical Research Experts to Its Scientific Advisory Board". Emeryville, CA. |
2021-04-07 |
| Achilles Therapeutics plc. (4/6/21). "Press Release: Achilles Therapeutics Announces Closing of $175.5 Million Initial Public Offering". London. |
2021-04-06 |
| ADC Therapeutics S.A.. (4/6/21). "Press Release: Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer". Boston, MA, Shanghai & Lausanne. |
2021-04-06 |
| OncoResponse, Inc.. (3/31/21). "Press Release: OncoResponse Raises $40.6 Million Series C Financing". Seattle, WA. |
2021-03-31 |
| Flagship Pioneering. (3/31/21). "Press Release: Flagship Pioneering Expands Leadership Team with Appointment of Michael T. Nally as CEO-Partner. Nally to Lead Generate Biomedicines as CEO". Cambridge, MA. |
2021-03-31 |
| Flagship Pioneering. (3/31/21). "Press Release: Flagship Pioneering Expands Biotech Footprint to Property in Somerville’s Boynton Yard. Four Flagship Start-ups Will Be First Occupants of New Space". Cambridge, MA. |
2021-03-31 |
| Rentschler Biopharma SE. (3/31/21). "Press Release: Rentschler Biopharma Appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation". Laupheim & Milford, MA. |
2021-03-31 |
| Pyxis Oncology. (3/30/21). "Press Release: Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics". Cambridge, MA. |
2021-03-30 |
| Achilles Therapeutics plc. (3/30/21). "Press Release: Achilles Therapeutics Announces Pricing of Initial Public Offering". London. |
2021-03-30 |
| Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces $148 Million Raised in Series C Financing". London. |
2021-03-26 |
| Gyroscope Therapeutics Ltd.. (3/26/21). "Press Release: Gyroscope Therapeutics Announces Additional Financing Plans". London. |
2021-03-26 |
| Olink Holding AB. (3/25/21). "Press Release: Olink Holding AB (publ) Announces Pricing of Initial Public Offering". Uppsala. |
2021-03-25 |
| Leyden Laboratories B.V.. (3/25/21). "Press Release: Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital". Ams |
2021-03-25 |
| Immuneering Corporation. (3/25/21). "Press Release: Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer". Cambridge, MA. |
2021-03-25 |
| Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde. |
2021-03-25 |
| Immunai. (3/25/21). "Press Release: Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities". New York, NY. |
2021-03-25 |
| Numares AG. (3/24/21). "Press Release: Numares Announces FDA 510(k) Submission of Axinon System, a NMR Platform for Metabolomics-based, AI-driven Diagnostics". Boston, MA & Regensburg. |
2021-03-24 |
| Enterome S.A.. (3/24/21). "Press Release: Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors". |
2021-03-24 |
| Scipher Medicine. (3/24/21). "Press Release: Scipher Medicine Announces $82 Million Financing". Waltham, MA. |
2021-03-24 |
| Merck & Co., Inc.. (3/24/21). "Press Release: Merck Appoints Caroline Litchfield Chief Financial Officer". Kenilworth, NJ. |
2021-03-24 |
| Lava Therapeutics B.V.. (3/24/21). "Press Release: Lava Therapeutics Announces Pricing of Initial Public Offering". Utrecht & Philadelphia, PA. |
2021-03-24 |
| Arix Bioscience plc. (3/24/21). "Press Release: Strategy Implementation Review". London. |
2021-03-24 |
| Metagenomi Inc.. (3/24/21). "Press Release: Metagenomi Expands Leadership Team, Accelerates Organizational Development with the Appointment of Jian Irish, Ph.D. as Chief Operating Officer". Emeryville, CA. |
2021-03-24 |
| Meatable. (3/23/21). "Press Release: Meatable Raises $47 Million Series A to Continue Scaling Trajectory and Expand its Product Portfolio with Beef". |
2021-03-23 |
| PhoreMost Ltd.. (3/23/21). "Press Release: PhoreMost Closes £33M ($46M) Series B Financing". Cambridge. |
2021-03-23 |
| Dunad Therapeutics. (3/23/21). "Press Release: Dunad Therapeutics Emerges to Develop Next-generation Small Molecule Therapeutics Based on First Tuneable Targeted Protein Degradation Technology". Cambridge. |
2021-03-23 |
| 1910 Genetics. (3/23/21). "Press Release: 1910 Genetics Debuts with $26M to Accelerate the Design of Small Molecule and Protein Therapeutics Through AI, Computation and Biological Automation". Cambridge, MA. |
2021-03-23 |
| Emalex Biosciences, Inc.. (3/23/21). "Press Release: Emalex Biosciences Raises $35 Million in Series C Preferred Stock to Advance Tourette Syndrome and Stuttering Clinical Trials". Chicago. |
2021-03-23 |
| EpimAb Biotherapeutics. (3/22/21). "Press Release: EpimAb Biotherapeutics Raises $120M in Series C Financing to Advance Bispecific Programs and Broaden Clinical Pipeline". Shanghai. |
2021-03-22 |
| Oppenheimer & Co. Inc.. (3/22/21). "Press Release: Oppenheimer Builds Out Healthcare Team to Support Accelerating Growth". New York, NY. |
2021-03-22 |
| Rentschler Biopharma SE. (3/22/21). "Press Release: Rentschler Biopharma and Leukocare Extend Service Offering with Joint U.S. Site". Geneva & Newton, MA. |
2021-03-22 |
| Evotec SE. (3/22/21). "Press Release: Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance". Hamburg. |
2021-03-22 |
| Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. |
2021-03-22 |
| Auro Biosciences, Inc.. (3/22/21). "Press Release: Aura Biosciences Announces Oversubscribed $80 Million Financing". Cambridge, MA. |
2021-03-22 |
| Relief Therapeutics Holding AG. (3/22/21). "Press Release: Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine D |
2021-03-22 |
| AlloVir, Inc.. (3/22/21). "Press Release: AlloVir Appoints Diana M. Brainard, M.D., as Chief Executive Officer, Effective May 17, 2021". Cambridge, MA. |
2021-03-22 |
| Novartis AG. (3/22/21). "Press Release: Novartis Appoints Karen Hale as Chief Legal Officer". Basel. |
2021-03-22 |
| Dotmatics Ltd.. (3/22/21). "Press Release: Insightful Science Joins Forces with Dotmatics to Form a Leading Cloud-First Scientific R&D Company". Bishop’s Stortford & San Diego, CA. |
2021-03-22 |
| Bruker Corporation. (3/18/21). "Press Release: Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics". San José, CA & Boston, MA. |
2021-03-18 |
| Nordic Nanovector ASA. (3/18/21). "Press Release: Nordic Nanovector Appoints Experienced Pharmaceutical Company Leader Peter L. Braun as Chief Executive Officer". Potsdam & Berlin. |
2021-03-18 |
| Indivumed GmbH. (3/18/21). "Press Release: Indivumed Announces Expansion into Drug Development, Formation of Ix Therapeutics. Joint Venture with Xlife Sciences". Hamburg. |
2021-03-18 |
| Life Sciences Partners (LSP). (3/18/21). "Press Release: LSP Announces Closing of Upsized $120 Million Nasdaq IPO of European Biotech Acquisition Corp (EBAC) Targeting European Biotech". Amsterdam. |
2021-03-18 |
| Aktis Oncology. (3/18/21). "Press Release: Aktis Oncology Announces $72m Series A Financing to Advance Breakthrought Radiopharmaceuticals to Treat Solid Tumors". Cambridge, MA. |
2021-03-18 |
| Vaccitech Ltd.. (3/17/21). "Press Release: Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results". Oxford. |
2021-03-17 |
| Amphista Therapeutics Ltd.. (3/17/21). "Press Release: Amphista Therapeutics Raises $53M in Oversubscribed Series B Round to Advance Next Generation Targeted Protein Degradation Assets". Glasgow. |
2021-03-17 |
| Advent France Biotechnology S.A.S.. (3/17/21). "Press Release: Advent France Biotechnology Appoints Alejo Chorny, PhD, as Operating Partner and Head of New Spanish Operations". Paris & Barcelona. |
2021-03-17 |
| Inflammatix, Inc.. (3/16/21). "Press Release: Inflammatix Secures $102 Million in Series D Financing Led by D1 Capital Partners to Commercialize Novel Host Response Diagnostics". Burlingame, CA. |
2021-03-16 |
| Leica Microsystems AG. (3/16/21). "Press Release: Leica Microsystems Acquires Aivia, a Leading AI-enabled 3D Microscopy, Image Visualization and Analysis Software Solution". Wetzlar. |
2021-03-16 |
| Ryvu Therapeutics. (3/16/21). "Press Release: Ryvu Therapeutics Reports Financial Results for 2020". Kraków. |
2021-03-16 |
| ElevateBio, LLC. (3/15/21). "Press Release: ElevateBio Scales Disruptive Cell and Gene Therapy Business Model with $525 Million Series C Financing". Cambridge, MA. |
2021-03-15 |
| Lava Therapeutics B.V.. (3/15/21). "Press Release: Lava Therapeutics B.V. Appoints Edward F. Smith as Chief Financial Officer". Utrecht & Philadelphia, PA. |
2021-03-15 |
| Univercells S.A.. (3/15/21). "Press Release: Univercells, Univercells Technologies and Gamma Biosciences Announce Mathias Garny as New CEO of Univercells Technologies". Brussels. |
2021-03-15 |
| Roche. (3/15/21). "Press Release: Roche Signs Definitive Merger Agreement with GenMark Diagnostics, Inc., to Access Novel Technology to Test for Broad Range of Pathogens with One Patient Sample". Basel. |
2021-03-15 |
| Cellink AB. (3/12/21). "Press Release: Cellink AB (publ) Announces the Completion of the Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Overall Amount of SEK 3.0 Billion [NOT FOR US, CA, AU, |
2021-03-12 |
| Monte Rosa Therapeutics. (3/12/21). "Press Release: Monte Rosa Therapeutics Announces $95 Million Series C Financing to Accelerate Next-generation Protein Degradation Platform". Boston, MA. |
2021-03-12 |
| Relief Therapeutics Holding AG. (3/12/21). "Press Release: Relief Announces CHF 10 Million Private Placement". Geneva. |
2021-03-12 |
| Cellink AB. (3/11/21). "Press Release: Cellink AB Announces an Offering of Senior Unsecured Convertible Bonds Convertible into Class B Shares and a Class B Share Issue in an Expected Amount of SEK 2.75 Billion [NOT FOR US, CA, et al.]". Gothenburg. |
2021-03-11 |
| Integrated DNA Technologies. (3/11/21). "Press Release: IDT Acquires Swift Biosciences, a Pioneer in the Development of Next-Generation Sequencing (NGS) Library Preparation Genomics Kits for Academic, Translational, and Clinical Research". Coralville, IA |
2021-03-11 |
| AgomAb Therapeutics N.V.. (3/10/21). "Press Release: AgomAb Therapeutics Raises $74 Million Series B to Advance Regenerative Pathway Modulators". Ghent. |
2021-03-10 |
| Cellink AB. (3/10/21). "Press Release: Cellink Has Entered into an Agreement to Acquire MatTek, the Global Leader in In-vitro Technology and Alternative Drug Testing Models". |
2021-03-10 |
| Valo Health LLC. (3/9/21). "Press Release: Valo Health Receives $110 Million In Funding From Koch Disruptive Technologies To Close Series B". Boston, MA. |
2021-03-09 |
| BioPhero ApS. (3/9/21). "Press Release: BioPhero Announces $17 Million Series A For Sustainable Pest Control". Copenhagen. |
2021-03-09 |
| Eli Lilly and Company. (3/8/21). "Press Release: Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes". Indianapolis, IN & Tel Aviv. |
2021-03-08 |
| Exscientia Ltd.. (3/4/21). "Press Release: Exscientia Completes $100 Million Series C Financing Round with BlackRock Funds". |
2021-03-04 |
| Amunix Pharmaceuticals, Inc.. (3/4/21). "Press Release: Amunix Raises $117 Million Series B Financing to Fund its Oncology Pipeline". South San Francisco, CA. |
2021-03-04 |
| Five Prime Therapeutics Inc.. (3/4/21). "Press Release: Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash". Thousand Oaks, CA & South San Francisco, CA. |
2021-03-04 |
| Bio-Techne Corporation. (3/3/21). "Press Release: Bio-Techne to Acquire Asuragen". Minneapolis, MN & Austin, TX. |
2021-03-03 |
| TrakCel Ltd.. (3/3/21). "Press Release: TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round". Cardiff. |
2021-03-03 |
| Atai Life Sciences AG. (3/3/21). "Press Release: Atai Life Sciences Announces the Closing of Its $157 Million Series D Financing Round". New York, NY. |
2021-03-03 |
| Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. |
2021-03-03 |
| Caribou Biosciences, Inc.. (3/3/21). "Press Release: Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline". Berkeley, CA. |
2021-03-03 |
| Janux Therapeutics. (3/3/21). "Press Release: Janux Therapeutics Announces $56 Million Series A to Advance Novel Cancer Drug Candidates using T Cell Engager (TRACTr) Technology". San Diego, CA. |
2021-03-03 |
| Royal Philips. (3/2/21). "Press Release: Shez Partovi to Succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer". Amsterdam. |
2021-03-02 |
| Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford. |
2021-03-02 |
| Shorla Pharma Ltd.. (3/2/21). "Press Release: Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer". Clonmel. |
2021-03-02 |
| Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern. |
2021-03-01 |
| Congenica Ltd.. (3/1/21). "Press Release: Congenica Appoints Kamraan Shariff as Chief Business Development Officer". Cambridge. |
2021-03-01 |
| Hologic, Inc.. (3/1/21). "Press Release: Hologic Acquires European Molecular Diagnostic Company Diagenode for Approximately $159 Million". Marlborough, MA. |
2021-03-01 |
| Gyroscope Therapeutics Ltd.. (3/1/21). "Press Release: Gyroscope Therapeutics Appoints Jessica Stitt as Chief Financial Officer". London. |
2021-03-01 |
| ERS Genomics Ltd.. (3/1/21). "Press Release: ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development". Dublin. |
2021-03-01 |
| Achilles Therapeutics plc. (3/1/21). "Press Release: Achilles Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States". London. |
2021-03-01 |
| EG 427. (3/1/21). "Press Release: EG 427 Announces €12 Million Series A Financing to Advance Its HSV-1 based Gene Therapy
David Lamond and Stephane Boissel join the company’s board of Directors". Paris. |
2021-03-01 |
| Pacific Biosciences of California, Inc.. (2/26/21). "Press Release: Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences". Menlo Park, CA. |
2021-02-26 |
| Oncopeptides AB. (2/26/21). "Press Release: FDA Approves Oncopeptides' Pepaxto (melphalan flufenamide) for Patients with Relapsed or Refractory Multiple Myeloma". Stockholm. |
2021-02-26 |
| Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA. |
2021-02-26 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo-2019.png){kind=logo}
Date![Picture [iito] Fighting Customers 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-fighting-customers.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
